4-(2,4-dichlorophenoxy)-N-[2-(4-phenylpiperazine-1-carbonyl)phenyl]butanamide
C27H27Cl2N3O3 — CID 17256499
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-(2,4-dichlorophenoxy)-N-[2-(4-phenylpiperazine-1-carbonyl)phenyl]butanamide
4-(2,4-dichlorophenoxy)-N-[2-(4-phenylpiperazine-1-carbonyl)phenyl]butanamide (PubChem CID 17256499) has the molecular formula C27H27Cl2N3O3 and a molecular weight of 512.44 g/mol. Its IUPAC name is 4-(2,4-dichlorophenoxy)-N-[2-(4-phenylpiperazine-1-carbonyl)phenyl]butanamide.
Molecular Properties
| Compound Name | 4-(2,4-dichlorophenoxy)-N-[2-(4-phenylpiperazine-1-carbonyl)phenyl]butanamide |
|---|---|
| PubChem CID | 17256499 |
| Molecular Formula | C27H27Cl2N3O3 |
| Molecular Weight | 512.44 g/mol |
| Exact Mass | 511.14 |
| IUPAC Name | 4-(2,4-dichlorophenoxy)-N-[2-(4-phenylpiperazine-1-carbonyl)phenyl]butanamide |
| SMILES | O=C(CCCOc1ccc(Cl)cc1Cl)Nc1ccccc1C(=O)N1CCN(c2ccccc2)CC1 |
| InChI | InChI=1S/C27H27Cl2N3O3/c28-20-12-13-25(23(29)19-20)35-18-6-11-26(33)30-24-10-5-4-9-22(24)27(34)32-16-14-31(15-17-32)21-7-2-1-3-8-21/h1-5,7-10,12-13,19H,6,11,14-18H2,(H,30,33) |
| InChIKey | JRQNLVDGZUGZSM-UHFFFAOYSA-N |
| XLogP | 5.75 |
| TPSA | 61.88 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 512.44 |
| LogP ≤ 5 | 5.75 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 17256499 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.